Influence of dosage and therapeutic interval on the incidence of severe side effects of immunotherapy with PD-1 inhibitors in malignant melanoma

EJC Skin Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles